Creatine and Creatinine Metabolism - Physiological Reviews

1200 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
duces changes in the level of mRNAs coding for stress protein 71
and creatine kinase M. Circ Res 63: 512–517, 1988.
631. MEKHFI H, HOERTER J, LAUER C, WISNEWSKY C, SCHWARTZ
K, AND VENTURA-CLAPIER R. Myocardial adaptation to creatine
deficiency in rats fed with �-guanidinopropionic acid, a creatine
analogue. Am J Physiol Heart Circ Physiol 258: H1151–H1158,
1990.
632. MEKHFI H, VEKSLER V, MATEO P, MAUPOIL V, ROCHETTE L,
AND VENTURA-CLAPIER R. Creatine kinase is the main target of
reactive oxygen species in cardiac myofibrils. Circ Res 78: 1016–
1027, 1996.
633. MESKYS R, RUDOMANSKIS R, AND LEIPUVIENE R. Cloning of
genes encoding heterotetrameric sarcosine oxidase from Arthrobacter
sp. Biotechnol Lett 18: 781–786, 1996.
634. METHFESSEL J. Transamidinase. Zschr Inn Med 25: 80–84, 1970.
635. MEYER MH, SMITH S, AND MEYER RA. Creatinine assay by the
Fuller’s earth procedure or by enzymatic determination is adequate
for urine but not plasma of mice. Comp Biochem Physiol B
Biochem 106: 685–689, 1993.
636. MEYER RA. Linear dependence of muscle phosphocreatine kinetics
on total creatine content. Am J Physiol Cell Physiol 257:
C1149–C1157, 1989.
637. MEYER RA, BROWN TR, KRILOWICZ BL, AND KUSHMERICK MJ.
Phosphagen and intracellular pH changes during contraction of
creatine-depleted rat muscle. Am J Physiol Cell Physiol 250:
C264–C274, 1986.
638. MIKAMI H, ORITA Y, ANDO A, FUJII M, KIKUCHI T, YOSHIHARA
K, OKADA A, AND ABE H. Metabolic pathway of guanidino compounds
in chronic renal failure. In: Urea Cycle Diseases, edited by
A. Lowenthal, A. Mori, and B. Marescau. New York: Plenum, 1982,
p. 449–458.
639. MILHORAT AT. Creatine and creatinine metabolism and diseases
of the neuro-muscular system. In: Metabolic and Toxic Diseases
of the Nervous System, edited by H. H. Merritt and C. C. Hare.
Baltimore, MD: Williams & Wilkins, 1953, p. 400–421.
640. MILLANVOYE-VAN BRUSSEL E, FREYSS-BEGUIN M, GRIFFA-
TON G, AND LECHAT P. Energy metabolism of cardiac cell cultures
during oxygen deprivation: effects of creatine and arachidonic
acid. Biochem Pharmacol 34: 145–147, 1985.
641. MILLER EE, EVANS AE, AND COHN M. Inhibition of rate of tumor
growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 90:
3304–3308, 1993.
642. MILLER K, HALOW J, AND KORETSKY AP. Phosphocreatine protects
transgenic mouse liver expressing creatine kinase from hypoxia
and ischemia. Am J Physiol Cell Physiol 265: C1544–C1551,
1993.
643. MILLER K, SHARER K, SUHAN J, AND KORETSKY AP. Expression
of functional mitochondrial creatine kinase in liver of transgenic
mice. Am J Physiol Cell Physiol 272: C1193–C1202, 1997.
644. MIN K-L, STEGHENS J-P, HENRY R, DOUTHEAU A, AND COL-
LOMBEL C. Identification of the creatine binding domain of creatine
kinase by photoaffinity labeling. Biochim Biophys Acta
1387: 80–88, 1998.
645. MIN K-L, STEGHENS J-P, HENRY R, DOUTHEAU A, AND COL-
LOMBEL C. Synthesis and differential properties of creatine analogues
as inhibitors for human creatine kinase isoenzymes. Eur
J Biochem 238: 446–452, 1996.
646. MINAJEVA A, VENTURA-CLAPIER R, AND VEKSLER V. Ca 2�
uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly
depends on bound creatine kinase. Pflügers Arch 432: 904–912,
1996.
647. MINDERHOUD JM, MOOYAART EL, KAMMAN RL, TEELKEN
AW, HOOGSTRATEN MC, VENCKEN LM, GRAVENMADE EJ, AND
VAN DEN BURG W. In vivo phosphorus magnetic resonance
spectroscopy in multiple sclerosis. Arch Neurol 49: 161–165, 1992.
648. MINKOFF L, GAERTNER G, DARAB M, MERCIER C, AND LEVIN
ML. Inhibition of brain sodium-potassium ATPase in uremic rats.
J Lab Clin Invest 80: 71–78, 1972.
649. MIRVISH SS. The etiology of gastric cancer. Intragastric nitrosamide
formation and other theories. J Natl Cancer Inst 71: 629–
647, 1983.
650. MIRVISH SS, CAIRNES DA, HERMES NH, AND RAHA CR. Creat-
inine: a food component that is nitrosated-denitrosated to yield
methylurea. J Agric Food Chem 30: 824–828, 1982.
651. MIRVISH SS, DESHPANDE A, HAIGHT R, NICKOLS J, MCWIL-
LIAMS N, BABCOOK DM, AND MORRIS CR. Creatinine nitrosation
to yield 5-oxocreatinine 5-oxime and 1-methyl-5-oxohydantoin
5-oxime: reaction rates, identification of syn and anti oxime
isomers, and their interconversion by nitrite. J Agric Food Chem
41: 2051–2055, 1993.
652. MITCH WE, COLLIER VU, AND WALSER M. Creatinine metabolism
in chronic renal failure. Clin Sci 58: 327–335, 1980.
653. MIURA T, MURAOKA S, AND OGISO T. Adriamycin-Fe 3� -induced
inactivation of rat heart mitochondrial creatine kinase: sensitivity
to lipid peroxidation. Biol Pharm Bull 17: 1220–1223, 1994.
654. MIYOSHI K, TAIRA A, YOSHIDA K, TAMURA K, AND UGA S.
Abnormalities of creatinase in skeletal muscle of patients with
Duchenne muscular dystrophy. Proc Jpn Acad 56: 99–101, 1980.
655. MIYOSHI K, TAIRA A, YOSHIDA K, TAMURA K, AND UGA S.
Presence of creatinase and sarcosine dehydrogenase in human
skeletal muscle. Proposal for creatine-urea pathway. Proc Jpn
Acad 56: 95–98, 1980.
656. MOERLAND TS AND KUSHMERICK MJ. Contractile economy and
aerobic recovery metabolism in skeletal muscle adapted to creatine
depletion. Am J Physiol Cell Physiol 267: C127–C137, 1994.
657. MOERLAND TS, WOLF NG, AND KUSHMERICK MJ. Administration
of a creatine analog induces isomyosin transitions in muscle.
Am J Physiol Cell Physiol 257: C810–C816, 1989.
658. MOKHTAR N, ROUSSEAU-MIGNERON S, TANCRÈDE G, AND
NADEAU A. Physical training attenuates phosphocreatine and
long-chain acyl-CoA alterations in diabetic rat heart. J Appl
Physiol 74: 1785–1790, 1993.
659. MÖLLER A AND HAMPRECHT B. Creatine transport in cultured
cells of rat and mouse brain. J Neurochem 52: 544–550, 1989.
660. MÖLLER B, HIPPE H, AND GOTTSCHALK G. Degradation of various
amine compounds by mesophilic clostridia. Arch Microbiol
145: 85–90, 1986.
661. MONTAGNA P. Magnetic resonance spectroscopy in migraine.
Cephalalgia 15: 323–327, 1995.
662. MONTAGNA P, LODI R, CORTELLI P, PIERANGELI G, IOTTI S,
CEVOLI S, ZANIOL P, AND BARBIROLI B. Phosphorus magnetic
resonance spectroscopy in cluster headache. Neurology 48: 113–
118, 1997.
663. MONTAGNA P, MARTINELLI P, CORTELLI P, ZANIOL P, LUGA-
RESI E, AND BARBIROLI B. Brain 31 P-magnetic resonance spectroscopy
in mitochondrial cytopathies. Ann Neurol 31: 451–452,
1992.
664. MOORE NP, GRAY TJB, AND TIMBRELL JA. Creatine metabolism
in the seminiferous epithelium of rats. I. Creatine synthesis by
isolated and cultured cells. J Reprod Fertil 112: 325–330, 1998.
665. MOORE NP, GRAY TJB, AND TIMBRELL JA. Creatine metabolism
in the seminiferous epithelium of rats. II. Effect of modulators of
cellular biochemical function on creatine secretion by cultured
Sertoli cells. J Reprod Fertil 112: 331–336, 1998.
666. MOOS C AND FENG I-NM. Pyrophosphate contamination in crystalline
phosphocreatine: a source of error in kinetic studies using
coupled enzymes. Anal Biochem 87: 272–277, 1978.
667. MORGELLO S, WOLFE D, GODFREY E, FEINSTEIN R, TAGLIATI
M, AND SIMPSON DM. Mitochondrial abnormalities in human
immunodeficiency virus-associated myopathy. Acta Neuropathol
90: 366–374, 1995.
668. MORRISON JF. Arginine kinase and other invertebrate guanidino
kinases. In: The Enzymes (3rd ed.), edited by P. D. Boyer. New
York: Academic, 1973, p. 457–486.
669. MORRISON JF AND ENNOR AH. N-phosphorylated guanidines. In:
The Enzymes (2nd ed.), edited by P. D. Boyer, H. Lardy, and K.
Myrbäck. New York: Academic, 1960, p. 89–109.
670. MORRISON LD, ELING TE, AND JOSEPHY PD. Prostaglandin H
synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline
(nitro-IQ) from IQ. Mutat Res
302: 45–52, 1993.
671. MUDD SH, EBERT MH, AND SCRIVER CR. Labile methyl group
balances in the human: the role of sarcosine. Metabolism 29:
707–720, 1980.
672. MÜHLEBACH SM, GROSS M, WIRZ T, WALLIMANN T, PERRI-